Miransertib
- Generic Name
- Miransertib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C27H24N6
- CAS Number
- 1313881-70-7
- Unique Ingredient Identifier
- T1DQI1B52Y
- Background
Miransertib is under investigation in clinical trial NCT01473095 (Phase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors and Recurrent Malignant Lymphoma).
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath